ClinConnect ClinConnect Logo
Search / Trial NCT05347550

Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients

Launched by IMPERIAL COLLEGE LONDON · Apr 25, 2022

Trial Information

Current as of November 08, 2025

Recruiting

Keywords

Cluster Venous Thromboembolism Deep Vein Thrombosis Pulmonary Embolism

ClinConnect Summary

This clinical trial is looking at whether wearing graduated compression stockings helps prevent blood clots in patients who are at low risk after having short surgeries. Blood clots can form in the legs and travel to the lungs, where they can be very dangerous. While these stockings are commonly used in hospitals to help reduce this risk, it's unclear if they are truly helpful for patients who are not at high risk of developing clots. Given that many patients undergo short surgeries each year and often wear these stockings, this study aims to find out if they are necessary for low-risk patients.

To participate in this study, individuals need to be adults aged 18 to 59 scheduled for surgery with a hospital stay of less than 48 hours and assessed as low-risk for blood clots. Those who qualify will be asked to wear the compression stockings during their hospital stay. The study will help determine if continuing to use these stockings is worthwhile, which could impact treatment practices and costs in the future. If you're considering participating, it’s important to know that there are certain health conditions that would exclude you from the trial, such as having a history of blood clots or needing specific treatments for blood clot prevention.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults (18-59 years of age) scheduled to undergo a surgical procedure with a hospital stay \<48 hours
  • Individuals assessed as being at low-risk of developing VTE as per the DHRA Tool (i.e. no assessed thrombosis risk factors / scoring 0)
  • Exclusion Criteria:
  • Individuals with a contraindication to GCS
  • Individuals assessed as being at moderate or high-risk of VTE as per the DHRA tool
  • Individuals requiring therapeutic anticoagulation
  • Individuals with thrombophilia/ thrombogenic disorder
  • Individuals with a previous history of VTE
  • Individuals requiring intermittent pneumatic compression therapy beyond theatre and recovery
  • Individuals requiring extended thromboprophylaxis beyond discharge
  • Female patients of childbearing age who have a positive pregnancy test
  • Individuals with lower limb immobilisation
  • Inability to provide informed consent

About Imperial College London

Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.

Locations

Newcastle Upon Tyne, United Kingdom

Middlesbrough, United Kingdom

Barnsley, United Kingdom

Stockton On Tees, United Kingdom

East Grinstead, United Kingdom

Camberley, United Kingdom

London, United Kingdom

Nottingham, United Kingdom

Taunton, United Kingdom

Patients applied

0 patients applied

Trial Officials

Alun Davies

Principal Investigator

Imperial College London

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials